BRISTOL MYERS SQUIBB CO (BMY)
Clinical trial NCT03455452 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-11-30 → 2025-12-18 3. primary completion date: 2025-11-30 → 2025-12-18 4. enrollment: 600 → 623 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (64%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (23%) **Content type:** Clinical